BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
963801	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29)	OEXMEESXYABYFA-UHFFFAOYSA-N	466535	4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429260	441576241							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963802	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29)	OEXMEESXYABYFA-UHFFFAOYSA-N	466535	4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1	D(4) dopamine receptor	Homo sapiens				 11.9					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429260	441576241							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963803	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-5,14-15H,2-3,6-13H2,(H,23,26)	IVMHGKYNLVHHQR-UHFFFAOYSA-N	466540	US10800755, Example 2	5-hydroxytryptamine receptor 1A	Human				 323					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466540&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922394	441576246							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963804	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-5,14-15H,2-3,6-13H2,(H,23,26)	IVMHGKYNLVHHQR-UHFFFAOYSA-N	466540	US10800755, Example 2	D(4) dopamine receptor	Homo sapiens				 58.9					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466540&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922394	441576246							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963805	Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1	InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24)	JQHNICFXWDNWAO-UHFFFAOYSA-N	466545	US10800755, Example 3::US11014905, Example 3	5-hydroxytryptamine receptor 1A	Human				 38.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922395	441576251							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963806	Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1	InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24)	JQHNICFXWDNWAO-UHFFFAOYSA-N	466545	US10800755, Example 3::US11014905, Example 3	D(4) dopamine receptor	Homo sapiens				 33.5					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922395	441576251							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963807	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26)	KQNGZWUJPKEOIL-UHFFFAOYSA-N	466547	US10800755, Example 4::US11014905, Example 4	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922396	441576253							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963808	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26)	KQNGZWUJPKEOIL-UHFFFAOYSA-N	466547	US10800755, Example 4::US11014905, Example 4	D(4) dopamine receptor	Homo sapiens				 25.1					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922396	441576253							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963809	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23)	HBHQINPAMGZPQL-UHFFFAOYSA-N	466549	US10800755, Example 5::US11014905, Example 5	5-hydroxytryptamine receptor 1A	Human				 42.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922397	441576255							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963810	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23)	HBHQINPAMGZPQL-UHFFFAOYSA-N	466549	US10800755, Example 5::US11014905, Example 5	D(4) dopamine receptor	Homo sapiens				 55.8					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922397	441576255							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963811	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26)	VLVHBCCFLHBDRZ-UHFFFAOYSA-N	466550	US10800755, Example 6::US11014905, Example 6	5-hydroxytryptamine receptor 1A	Human				 44.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922398	441576256							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963812	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26)	VLVHBCCFLHBDRZ-UHFFFAOYSA-N	466550	US10800755, Example 6::US11014905, Example 6	D(4) dopamine receptor	Homo sapiens				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922398	441576256							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963813	COCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-27-13-18(7-8-18)17(26)23-9-12-25-10-5-14(6-11-25)15-3-2-4-16(24-15)19(20,21)22/h2-4,14H,5-13H2,1H3,(H,23,26)	NEDKIEZVBKFWHQ-UHFFFAOYSA-N	466551	US10800755, Example 7	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466551&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922399	441576257							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963814	COCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-27-13-18(7-8-18)17(26)23-9-12-25-10-5-14(6-11-25)15-3-2-4-16(24-15)19(20,21)22/h2-4,14H,5-13H2,1H3,(H,23,26)	NEDKIEZVBKFWHQ-UHFFFAOYSA-N	466551	US10800755, Example 7	D(4) dopamine receptor	Homo sapiens				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466551&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922399	441576257							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963815	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23)	MMZCHCQVBLYIRF-UHFFFAOYSA-N	466552	N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429277	441576258							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963816	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23)	MMZCHCQVBLYIRF-UHFFFAOYSA-N	466552	N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8	D(4) dopamine receptor	Homo sapiens				 37.1					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429277	441576258							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963817	CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25)	WRRJZZBXRRDBBD-UHFFFAOYSA-N	466553	US10800755, Example 9::US11014905, Example 9	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429268	441576259							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963818	CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25)	WRRJZZBXRRDBBD-UHFFFAOYSA-N	466553	US10800755, Example 9::US11014905, Example 9	D(4) dopamine receptor	Homo sapiens				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429268	441576259							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963819	Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22)	UDFOPUAGEBDRJQ-UHFFFAOYSA-N	466554	US10800755, Example 10::US11014905, Example 10	5-hydroxytryptamine receptor 1A	Human				 10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922400	441576260							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963820	Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22)	UDFOPUAGEBDRJQ-UHFFFAOYSA-N	466554	US10800755, Example 10::US11014905, Example 10	D(4) dopamine receptor	Homo sapiens				 10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922400	441576260							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963821	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	OASSGMBDTDTXKO-UHFFFAOYSA-N	466555	US10800755, Example 11::US11014905, Example 11	5-hydroxytryptamine receptor 1A	Human				 82.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429261	441576261							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963822	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	OASSGMBDTDTXKO-UHFFFAOYSA-N	466555	US10800755, Example 11::US11014905, Example 11	D(4) dopamine receptor	Homo sapiens				 30.8					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429261	441576261							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963823	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29)	CFQKEDUZBWAPMC-UHFFFAOYSA-N	466556	4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429255	441576262							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963824	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29)	CFQKEDUZBWAPMC-UHFFFAOYSA-N	466556	4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12	D(4) dopamine receptor	Homo sapiens				 35.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429255	441576262							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963825	Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1	WOHMWCGVHSYPFG-JENIJYKNSA-N	466557	US10800755, Example 13::US11014905, Example 13	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330155	441576263							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963826	Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1	WOHMWCGVHSYPFG-JENIJYKNSA-N	466557	US10800755, Example 13::US11014905, Example 13	D(4) dopamine receptor	Homo sapiens				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330155	441576263							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963827	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26)	SKSOBHHSERUEOI-UHFFFAOYSA-N	466559	US10800755, Example 14::US11014905, Example 14	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146329996	441576265							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963828	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26)	SKSOBHHSERUEOI-UHFFFAOYSA-N	466559	US10800755, Example 14::US11014905, Example 14	D(4) dopamine receptor	Homo sapiens				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329996	441576265							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963829	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23)	NKLHZQQLECBIFS-UHFFFAOYSA-N	466560	US10800755, Example 15::US11014905, Example 15	5-hydroxytryptamine receptor 1A	Human				 100.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146329997	441576266							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963830	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23)	NKLHZQQLECBIFS-UHFFFAOYSA-N	466560	US10800755, Example 15::US11014905, Example 15	D(4) dopamine receptor	Homo sapiens				 41.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329997	441576266							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963831	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26)	LUQGVAHGIPCKGZ-UHFFFAOYSA-N	466561	N-{2-[6-(Trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16	5-hydroxytryptamine receptor 1A	Human				 43.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429276	441576267							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963832	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26)	LUQGVAHGIPCKGZ-UHFFFAOYSA-N	466561	N-{2-[6-(Trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16	D(4) dopamine receptor	Homo sapiens				 31.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429276	441576267							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963833	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(C)n1	InChI=1S/C19H29N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-8H,9-14H2,1-4H3,(H,20,23)	IHQWOBBDTIBCNB-UHFFFAOYSA-N	466562	US10800755, Example 17::US11014905, Example 17	5-hydroxytryptamine receptor 1A	Human				 94.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466562&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330227	441576268							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963834	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(C)n1	InChI=1S/C19H29N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-8H,9-14H2,1-4H3,(H,20,23)	IHQWOBBDTIBCNB-UHFFFAOYSA-N	466562	US10800755, Example 17::US11014905, Example 17	D(4) dopamine receptor	Homo sapiens				 44.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466562&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330227	441576268							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963835	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26)	QKTXOFXCKWUIEE-UHFFFAOYSA-N	466564	US10800755, Example 18::US11014905, Example 18	5-hydroxytryptamine receptor 1A	Human				 68.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330226	441576270							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963836	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26)	QKTXOFXCKWUIEE-UHFFFAOYSA-N	466564	US10800755, Example 18::US11014905, Example 18	D(4) dopamine receptor	Homo sapiens				 37.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330226	441576270							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963837	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-4,15H,5-13H2,(H,23,26)	GOLUWUPEFVOPGA-UHFFFAOYSA-N	466565	US10800755, Example 19::US11014905, Example 19	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466565&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330084	441576271							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963838	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-4,15H,5-13H2,(H,23,26)	GOLUWUPEFVOPGA-UHFFFAOYSA-N	466565	US10800755, Example 19::US11014905, Example 19	D(4) dopamine receptor	Homo sapiens				 9.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466565&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330084	441576271							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963839	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCCCO2)CC1	InChI=1S/C19H27N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,8,18H,2-3,7,9-14H2,1H3,(H,20,23)	MRPRDAAKTDVUPC-UHFFFAOYSA-N	466566	US10800755, Example 20	5-hydroxytryptamine receptor 1A	Human				 57.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466566&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155196358	441576272							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963840	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCCCO2)CC1	InChI=1S/C19H27N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,8,18H,2-3,7,9-14H2,1H3,(H,20,23)	MRPRDAAKTDVUPC-UHFFFAOYSA-N	466566	US10800755, Example 20	D(4) dopamine receptor	Homo sapiens				 15.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466566&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155196358	441576272							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963841	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1	LGQIOUYNFUYGTH-YQQAZPJKSA-N	466567	US10800755, Example 21::US11014905, Example 21	5-hydroxytryptamine receptor 1A	Human				 84.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330153	441576273							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963842	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1	LGQIOUYNFUYGTH-YQQAZPJKSA-N	466567	US10800755, Example 21::US11014905, Example 21	D(4) dopamine receptor	Homo sapiens				 65.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330153	441576273							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963843	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H27N3O2/c1-14-3-2-4-17(20-14)15-5-9-21(10-6-15)11-8-19-18(22)16-7-12-23-13-16/h2-4,15-16H,5-13H2,1H3,(H,19,22)	ATMCUVOQKLCNNV-UHFFFAOYSA-N	466568	US10800755, Example 22::US11014905, Example 22	5-hydroxytryptamine receptor 1A	Human				 595					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466568&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330163	441576274							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963844	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H27N3O2/c1-14-3-2-4-17(20-14)15-5-9-21(10-6-15)11-8-19-18(22)16-7-12-23-13-16/h2-4,15-16H,5-13H2,1H3,(H,19,22)	ATMCUVOQKLCNNV-UHFFFAOYSA-N	466568	US10800755, Example 22::US11014905, Example 22	D(4) dopamine receptor	Homo sapiens				 57.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466568&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330163	441576274							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963845	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25)	GGSIQDWKWRXJBY-UHFFFAOYSA-N	466569	US10800755, Example 23::US11014905, Example 25	5-hydroxytryptamine receptor 1A	Human				 632					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330154	441576275							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963846	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25)	GGSIQDWKWRXJBY-UHFFFAOYSA-N	466569	US10800755, Example 23::US11014905, Example 25	D(4) dopamine receptor	Homo sapiens				 62.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330154	441576275							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963847	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H27N3O2/c1-14-4-2-5-16(20-14)15-7-10-21(11-8-15)12-9-19-18(22)17-6-3-13-23-17/h2,4-5,15,17H,3,6-13H2,1H3,(H,19,22)	NNKUZJKXZYNHAK-UHFFFAOYSA-N	466570	US10800755, Example 24::US11014905, Example 24	5-hydroxytryptamine receptor 1A	Human				 67.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466570&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330164	441576276							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963848	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H27N3O2/c1-14-4-2-5-16(20-14)15-7-10-21(11-8-15)12-9-19-18(22)17-6-3-13-23-17/h2,4-5,15,17H,3,6-13H2,1H3,(H,19,22)	NNKUZJKXZYNHAK-UHFFFAOYSA-N	466570	US10800755, Example 24::US11014905, Example 24	D(4) dopamine receptor	Homo sapiens				 32.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466570&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330164	441576276							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963849	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-5-1-3-14(23-16)13-6-9-24(10-7-13)11-8-22-17(25)15-4-2-12-26-15/h1,3,5,13,15H,2,4,6-12H2,(H,22,25)	VEDJDJXYSXQHNT-UHFFFAOYSA-N	466571	US10800755, Example 25	5-hydroxytryptamine receptor 1A	Human				 67.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466571&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146360827	441576277							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963850	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-5-1-3-14(23-16)13-6-9-24(10-7-13)11-8-22-17(25)15-4-2-12-26-15/h1,3,5,13,15H,2,4,6-12H2,(H,22,25)	VEDJDJXYSXQHNT-UHFFFAOYSA-N	466571	US10800755, Example 25	D(4) dopamine receptor	Homo sapiens				 30.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466571&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146360827	441576277							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963851	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C21H33N3O2/c1-16-4-3-5-20(23-16)17-10-13-24(14-11-17)15-12-22-21(25)18-6-8-19(26-2)9-7-18/h3-5,17-19H,6-15H2,1-2H3,(H,22,25)/t18-,19-	OFDPWRMPOMJNHU-WGSAOQKQSA-N	466572	US10800755, Example 26::US11014905, Example 26	5-hydroxytryptamine receptor 1A	Human				 395					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466572&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330165	441576278							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963852	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C21H33N3O2/c1-16-4-3-5-20(23-16)17-10-13-24(14-11-17)15-12-22-21(25)18-6-8-19(26-2)9-7-18/h3-5,17-19H,6-15H2,1-2H3,(H,22,25)/t18-,19-	OFDPWRMPOMJNHU-WGSAOQKQSA-N	466572	US10800755, Example 26::US11014905, Example 26	D(4) dopamine receptor	Homo sapiens				 3389					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466572&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330165	441576278							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963853	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C21H30F3N3O2/c1-29-17-7-5-16(6-8-17)20(28)25-11-14-27-12-9-15(10-13-27)18-3-2-4-19(26-18)21(22,23)24/h2-4,15-17H,5-14H2,1H3,(H,25,28)/t16-,17-	DFQSHXTUDLODFA-QAQDUYKDSA-N	466573	US10800755, Example 27::US11014905, Example 27	5-hydroxytryptamine receptor 1A	Human				 570					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466573&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330085	441576279							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963854	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C21H30F3N3O2/c1-29-17-7-5-16(6-8-17)20(28)25-11-14-27-12-9-15(10-13-27)18-3-2-4-19(26-18)21(22,23)24/h2-4,15-17H,5-14H2,1H3,(H,25,28)/t16-,17-	DFQSHXTUDLODFA-QAQDUYKDSA-N	466573	US10800755, Example 27::US11014905, Example 27	D(4) dopamine receptor	Homo sapiens				 1648					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466573&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330085	441576279							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963855	FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	CRIIWZWMEASXGQ-UHFFFAOYSA-N	466574	US10800755, Example 28::US11014905, Example 28	5-hydroxytryptamine receptor 1A	Human				 47.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330152	441576280							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963856	FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	CRIIWZWMEASXGQ-UHFFFAOYSA-N	466574	US10800755, Example 28::US11014905, Example 28	D(4) dopamine receptor	Homo sapiens				 37.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330152	441576280							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963857	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23)	LWUCNZZPRVNCLB-UHFFFAOYSA-N	466575	N-[2-(6-Methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242;(2&#8242;H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29	5-hydroxytryptamine receptor 1A	Human				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429259	441576281							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963858	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23)	LWUCNZZPRVNCLB-UHFFFAOYSA-N	466575	N-[2-(6-Methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242;(2&#8242;H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29	D(4) dopamine receptor	Homo sapiens				 24.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429259	441576281							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963859	Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22)	NSRFWSBDKAVEHH-UHFFFAOYSA-N	466576	2,2-Dimethyl-N-[2-(6-methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30	5-hydroxytryptamine receptor 1A	Human				 27.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429266	441576282							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963860	Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22)	NSRFWSBDKAVEHH-UHFFFAOYSA-N	466576	2,2-Dimethyl-N-[2-(6-methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30	D(4) dopamine receptor	Homo sapiens				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429266	441576282							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963861	CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25)	MLIIQBGETYKWJT-UHFFFAOYSA-N	466577	2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31	5-hydroxytryptamine receptor 1A	Human				 35.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429285	441576283							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963862	CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25)	MLIIQBGETYKWJT-UHFFFAOYSA-N	466577	2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31	D(4) dopamine receptor	Homo sapiens				<10.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429285	441576283							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963863	Fc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H26FN3O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H,20,23)	BUJBIVXDBXZHAP-UHFFFAOYSA-N	466578	US10800755, Example 32::US11014905, Example 32	5-hydroxytryptamine receptor 1A	Human				 67.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466578&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330087	441576284							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963864	Fc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H26FN3O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H,20,23)	BUJBIVXDBXZHAP-UHFFFAOYSA-N	466578	US10800755, Example 32::US11014905, Example 32	D(4) dopamine receptor	Homo sapiens				 7.00					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466578&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330087	441576284							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963865	COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23)	NOINDEFTVTZLJT-UHFFFAOYSA-N	466579	US10800755, Example 33::US11014905, Example 33	5-hydroxytryptamine receptor 1A	Human				 22.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330158	441576285							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963866	COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23)	NOINDEFTVTZLJT-UHFFFAOYSA-N	466579	US10800755, Example 33::US11014905, Example 33	D(4) dopamine receptor	Homo sapiens				 13.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330158	441576285							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963867	FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25)	BRSILCSYDNFMAA-UHFFFAOYSA-N	466580	US10800755, Example 34::US11014905, Example 34	5-hydroxytryptamine receptor 1A	Human				 22.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146329998	441576286							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963868	FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25)	BRSILCSYDNFMAA-UHFFFAOYSA-N	466580	US10800755, Example 34::US11014905, Example 34	D(4) dopamine receptor	Homo sapiens				 15.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329998	441576286							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963869	O=C(NCCN1CCC(CC1)c1cccc(n1)C#N)C1CCOCC1	InChI=1S/C19H26N4O2/c20-14-17-2-1-3-18(22-17)15-4-9-23(10-5-15)11-8-21-19(24)16-6-12-25-13-7-16/h1-3,15-16H,4-13H2,(H,21,24)	AYKNCXDOPYPPJV-UHFFFAOYSA-N	466581	N-{2-[4-(6-Cyanopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 35::US11014905, Example 35	5-hydroxytryptamine receptor 1A	Human				 525					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466581&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429258	441576287							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963870	O=C(NCCN1CCC(CC1)c1cccc(n1)C#N)C1CCOCC1	InChI=1S/C19H26N4O2/c20-14-17-2-1-3-18(22-17)15-4-9-23(10-5-15)11-8-21-19(24)16-6-12-25-13-7-16/h1-3,15-16H,4-13H2,(H,21,24)	AYKNCXDOPYPPJV-UHFFFAOYSA-N	466581	N-{2-[4-(6-Cyanopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 35::US11014905, Example 35	D(4) dopamine receptor	Homo sapiens				 64.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466581&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429258	441576287							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963871	Nc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H28N4O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H2,19,21)(H,20,23)	MMJQZWCPJZFPIH-UHFFFAOYSA-N	466582	N-{2-[4-(6-Aminopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 36::US11014905, Example 36	5-hydroxytryptamine receptor 1A	Human				 279					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466582&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429270	441576288							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963872	Nc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H28N4O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H2,19,21)(H,20,23)	MMJQZWCPJZFPIH-UHFFFAOYSA-N	466582	N-{2-[4-(6-Aminopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 36::US11014905, Example 36	D(4) dopamine receptor	Homo sapiens				 31.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466582&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429270	441576288							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963873	CNc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H30N4O2/c1-20-18-4-2-3-17(22-18)15-5-10-23(11-6-15)12-9-21-19(24)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,22)(H,21,24)	MAOSODQBBXGYHQ-UHFFFAOYSA-N	466583	N-(2-{4-[6-(Methylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 37::US11014905, Example 37	5-hydroxytryptamine receptor 1A	Human				 343					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466583&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429271	441576289							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963874	CNc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H30N4O2/c1-20-18-4-2-3-17(22-18)15-5-10-23(11-6-15)12-9-21-19(24)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,22)(H,21,24)	MAOSODQBBXGYHQ-UHFFFAOYSA-N	466583	N-(2-{4-[6-(Methylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 37::US11014905, Example 37	D(4) dopamine receptor	Homo sapiens				 52.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466583&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429271	441576289							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963875	CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25)	CRPFIYXBQORQJX-UHFFFAOYSA-N	466584	N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38	5-hydroxytryptamine receptor 1A	Human				 86.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429287	441576290							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963876	CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25)	CRPFIYXBQORQJX-UHFFFAOYSA-N	466584	N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38	D(4) dopamine receptor	Homo sapiens				 42.0					US Patent		10.7270/Q2TM7F5J		aid1804884	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429287	441576290							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963877	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29)	OEXMEESXYABYFA-UHFFFAOYSA-N	466535	4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1	5-hydroxytryptamine receptor 1A	Human		 0.400							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429260	441576241							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963878	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29)	OEXMEESXYABYFA-UHFFFAOYSA-N	466535	4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1	D(4) dopamine receptor	Homo sapiens		 11.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429260	441576241							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963879	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29)	OEXMEESXYABYFA-UHFFFAOYSA-N	466535	4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1	D(2) dopamine receptor	Homo sapiens		 1144							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429260	441576241							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963880	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-5,14-15H,2-3,6-13H2,(H,23,26)	IVMHGKYNLVHHQR-UHFFFAOYSA-N	466540	US10800755, Example 2	5-hydroxytryptamine receptor 1A	Human		 11.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466540&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922394	441576246							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963881	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-5,14-15H,2-3,6-13H2,(H,23,26)	IVMHGKYNLVHHQR-UHFFFAOYSA-N	466540	US10800755, Example 2	D(4) dopamine receptor	Homo sapiens		 109							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466540&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922394	441576246							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963882	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-5,14-15H,2-3,6-13H2,(H,23,26)	IVMHGKYNLVHHQR-UHFFFAOYSA-N	466540	US10800755, Example 2	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466540&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922394	441576246							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963883	Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1	InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24)	JQHNICFXWDNWAO-UHFFFAOYSA-N	466545	US10800755, Example 3::US11014905, Example 3	5-hydroxytryptamine receptor 1A	Human		 7.10							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922395	441576251							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963884	Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1	InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24)	JQHNICFXWDNWAO-UHFFFAOYSA-N	466545	US10800755, Example 3::US11014905, Example 3	D(4) dopamine receptor	Homo sapiens		 198							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922395	441576251							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963885	Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1	InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24)	JQHNICFXWDNWAO-UHFFFAOYSA-N	466545	US10800755, Example 3::US11014905, Example 3	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922395	441576251							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963886	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26)	KQNGZWUJPKEOIL-UHFFFAOYSA-N	466547	US10800755, Example 4::US11014905, Example 4	5-hydroxytryptamine receptor 1A	Human		 0.400							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922396	441576253							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963887	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26)	KQNGZWUJPKEOIL-UHFFFAOYSA-N	466547	US10800755, Example 4::US11014905, Example 4	D(4) dopamine receptor	Homo sapiens		 26.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922396	441576253							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963888	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26)	KQNGZWUJPKEOIL-UHFFFAOYSA-N	466547	US10800755, Example 4::US11014905, Example 4	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922396	441576253							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963889	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23)	HBHQINPAMGZPQL-UHFFFAOYSA-N	466549	US10800755, Example 5::US11014905, Example 5	5-hydroxytryptamine receptor 1A	Human		 80.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922397	441576255							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963890	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23)	HBHQINPAMGZPQL-UHFFFAOYSA-N	466549	US10800755, Example 5::US11014905, Example 5	D(4) dopamine receptor	Homo sapiens		 170							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922397	441576255							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963891	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23)	HBHQINPAMGZPQL-UHFFFAOYSA-N	466549	US10800755, Example 5::US11014905, Example 5	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922397	441576255							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963892	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26)	VLVHBCCFLHBDRZ-UHFFFAOYSA-N	466550	US10800755, Example 6::US11014905, Example 6	5-hydroxytryptamine receptor 1A	Human		 37.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922398	441576256							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963893	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26)	VLVHBCCFLHBDRZ-UHFFFAOYSA-N	466550	US10800755, Example 6::US11014905, Example 6	D(4) dopamine receptor	Homo sapiens		 101							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922398	441576256							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963894	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26)	VLVHBCCFLHBDRZ-UHFFFAOYSA-N	466550	US10800755, Example 6::US11014905, Example 6	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922398	441576256							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963895	COCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-27-13-18(7-8-18)17(26)23-9-12-25-10-5-14(6-11-25)15-3-2-4-16(24-15)19(20,21)22/h2-4,14H,5-13H2,1H3,(H,23,26)	NEDKIEZVBKFWHQ-UHFFFAOYSA-N	466551	US10800755, Example 7	5-hydroxytryptamine receptor 1A	Human		 13.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466551&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922399	441576257							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963896	COCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-27-13-18(7-8-18)17(26)23-9-12-25-10-5-14(6-11-25)15-3-2-4-16(24-15)19(20,21)22/h2-4,14H,5-13H2,1H3,(H,23,26)	NEDKIEZVBKFWHQ-UHFFFAOYSA-N	466551	US10800755, Example 7	D(4) dopamine receptor	Homo sapiens		 43.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466551&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922399	441576257							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963897	COCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-27-13-18(7-8-18)17(26)23-9-12-25-10-5-14(6-11-25)15-3-2-4-16(24-15)19(20,21)22/h2-4,14H,5-13H2,1H3,(H,23,26)	NEDKIEZVBKFWHQ-UHFFFAOYSA-N	466551	US10800755, Example 7	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466551&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922399	441576257							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963898	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23)	MMZCHCQVBLYIRF-UHFFFAOYSA-N	466552	N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8	5-hydroxytryptamine receptor 1A	Human		 1.40							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429277	441576258							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963899	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23)	MMZCHCQVBLYIRF-UHFFFAOYSA-N	466552	N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8	D(4) dopamine receptor	Homo sapiens		 111							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429277	441576258							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963900	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23)	MMZCHCQVBLYIRF-UHFFFAOYSA-N	466552	N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429277	441576258							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963901	CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25)	WRRJZZBXRRDBBD-UHFFFAOYSA-N	466553	US10800755, Example 9::US11014905, Example 9	5-hydroxytryptamine receptor 1A	Human		 1.10							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429268	441576259							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963902	CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25)	WRRJZZBXRRDBBD-UHFFFAOYSA-N	466553	US10800755, Example 9::US11014905, Example 9	D(4) dopamine receptor	Homo sapiens		 8.00							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429268	441576259							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963903	CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25)	WRRJZZBXRRDBBD-UHFFFAOYSA-N	466553	US10800755, Example 9::US11014905, Example 9	D(2) dopamine receptor	Homo sapiens		 2443							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429268	441576259							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963904	Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22)	UDFOPUAGEBDRJQ-UHFFFAOYSA-N	466554	US10800755, Example 10::US11014905, Example 10	5-hydroxytryptamine receptor 1A	Human		 1.40							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155922400	441576260							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963905	Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22)	UDFOPUAGEBDRJQ-UHFFFAOYSA-N	466554	US10800755, Example 10::US11014905, Example 10	D(4) dopamine receptor	Homo sapiens		 19.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922400	441576260							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963906	Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22)	UDFOPUAGEBDRJQ-UHFFFAOYSA-N	466554	US10800755, Example 10::US11014905, Example 10	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155922400	441576260							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963907	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	OASSGMBDTDTXKO-UHFFFAOYSA-N	466555	US10800755, Example 11::US11014905, Example 11	5-hydroxytryptamine receptor 1A	Human		 2.10							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429261	441576261							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963908	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	OASSGMBDTDTXKO-UHFFFAOYSA-N	466555	US10800755, Example 11::US11014905, Example 11	D(4) dopamine receptor	Homo sapiens		 44.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429261	441576261							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963909	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	OASSGMBDTDTXKO-UHFFFAOYSA-N	466555	US10800755, Example 11::US11014905, Example 11	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429261	441576261							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963910	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29)	CFQKEDUZBWAPMC-UHFFFAOYSA-N	466556	4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12	5-hydroxytryptamine receptor 1A	Human		 0.200							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429255	441576262							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963911	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29)	CFQKEDUZBWAPMC-UHFFFAOYSA-N	466556	4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12	D(4) dopamine receptor	Homo sapiens		 4.50							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429255	441576262							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963912	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29)	CFQKEDUZBWAPMC-UHFFFAOYSA-N	466556	4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12	D(2) dopamine receptor	Homo sapiens		 357							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429255	441576262							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963913	Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1	WOHMWCGVHSYPFG-JENIJYKNSA-N	466557	US10800755, Example 13::US11014905, Example 13	5-hydroxytryptamine receptor 1A	Human		 1.10							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330155	441576263							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963914	Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1	WOHMWCGVHSYPFG-JENIJYKNSA-N	466557	US10800755, Example 13::US11014905, Example 13	D(4) dopamine receptor	Homo sapiens		 24.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330155	441576263							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963915	Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1	WOHMWCGVHSYPFG-JENIJYKNSA-N	466557	US10800755, Example 13::US11014905, Example 13	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330155	441576263							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963916	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26)	SKSOBHHSERUEOI-UHFFFAOYSA-N	466559	US10800755, Example 14::US11014905, Example 14	5-hydroxytryptamine receptor 1A	Human		 0.100							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146329996	441576265							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963917	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26)	SKSOBHHSERUEOI-UHFFFAOYSA-N	466559	US10800755, Example 14::US11014905, Example 14	D(4) dopamine receptor	Homo sapiens		 3.00							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329996	441576265							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963918	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26)	SKSOBHHSERUEOI-UHFFFAOYSA-N	466559	US10800755, Example 14::US11014905, Example 14	D(2) dopamine receptor	Homo sapiens		 2438							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329996	441576265							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963919	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23)	NKLHZQQLECBIFS-UHFFFAOYSA-N	466560	US10800755, Example 15::US11014905, Example 15	5-hydroxytryptamine receptor 1A	Human		 13.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146329997	441576266							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963920	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23)	NKLHZQQLECBIFS-UHFFFAOYSA-N	466560	US10800755, Example 15::US11014905, Example 15	D(4) dopamine receptor	Homo sapiens		 505							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329997	441576266							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963921	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23)	NKLHZQQLECBIFS-UHFFFAOYSA-N	466560	US10800755, Example 15::US11014905, Example 15	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329997	441576266							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963922	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26)	LUQGVAHGIPCKGZ-UHFFFAOYSA-N	466561	N-{2-[6-(Trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16	5-hydroxytryptamine receptor 1A	Human		 6.00							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429276	441576267							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963923	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26)	LUQGVAHGIPCKGZ-UHFFFAOYSA-N	466561	N-{2-[6-(Trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16	D(4) dopamine receptor	Homo sapiens		 27.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429276	441576267							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963924	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26)	LUQGVAHGIPCKGZ-UHFFFAOYSA-N	466561	N-{2-[6-(Trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16	D(2) dopamine receptor	Homo sapiens		 1688							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429276	441576267							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963925	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(C)n1	InChI=1S/C19H29N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-8H,9-14H2,1-4H3,(H,20,23)	IHQWOBBDTIBCNB-UHFFFAOYSA-N	466562	US10800755, Example 17::US11014905, Example 17	5-hydroxytryptamine receptor 1A	Human		 26.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466562&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330227	441576268							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963926	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(C)n1	InChI=1S/C19H29N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-8H,9-14H2,1-4H3,(H,20,23)	IHQWOBBDTIBCNB-UHFFFAOYSA-N	466562	US10800755, Example 17::US11014905, Example 17	D(4) dopamine receptor	Homo sapiens		 91.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466562&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330227	441576268							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963927	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(C)n1	InChI=1S/C19H29N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-8H,9-14H2,1-4H3,(H,20,23)	IHQWOBBDTIBCNB-UHFFFAOYSA-N	466562	US10800755, Example 17::US11014905, Example 17	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466562	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466562&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330227	441576268							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963928	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26)	QKTXOFXCKWUIEE-UHFFFAOYSA-N	466564	US10800755, Example 18::US11014905, Example 18	5-hydroxytryptamine receptor 1A	Human		 21.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330226	441576270							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963929	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26)	QKTXOFXCKWUIEE-UHFFFAOYSA-N	466564	US10800755, Example 18::US11014905, Example 18	D(4) dopamine receptor	Homo sapiens		 19.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330226	441576270							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963930	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26)	QKTXOFXCKWUIEE-UHFFFAOYSA-N	466564	US10800755, Example 18::US11014905, Example 18	D(2) dopamine receptor	Homo sapiens		 2209							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330226	441576270							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963931	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-4,15H,5-13H2,(H,23,26)	GOLUWUPEFVOPGA-UHFFFAOYSA-N	466565	US10800755, Example 19::US11014905, Example 19	5-hydroxytryptamine receptor 1A	Human		 0.800							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466565&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330084	441576271							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963932	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-4,15H,5-13H2,(H,23,26)	GOLUWUPEFVOPGA-UHFFFAOYSA-N	466565	US10800755, Example 19::US11014905, Example 19	D(4) dopamine receptor	Homo sapiens		 8.00							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466565&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330084	441576271							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963933	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-4,15H,5-13H2,(H,23,26)	GOLUWUPEFVOPGA-UHFFFAOYSA-N	466565	US10800755, Example 19::US11014905, Example 19	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466565	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466565&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330084	441576271							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963934	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCCCO2)CC1	InChI=1S/C19H27N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,8,18H,2-3,7,9-14H2,1H3,(H,20,23)	MRPRDAAKTDVUPC-UHFFFAOYSA-N	466566	US10800755, Example 20	5-hydroxytryptamine receptor 1A	Human		 6.80							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466566&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			155196358	441576272							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963935	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCCCO2)CC1	InChI=1S/C19H27N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,8,18H,2-3,7,9-14H2,1H3,(H,20,23)	MRPRDAAKTDVUPC-UHFFFAOYSA-N	466566	US10800755, Example 20	D(4) dopamine receptor	Homo sapiens		 92.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466566&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155196358	441576272							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963936	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCCCO2)CC1	InChI=1S/C19H27N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,8,18H,2-3,7,9-14H2,1H3,(H,20,23)	MRPRDAAKTDVUPC-UHFFFAOYSA-N	466566	US10800755, Example 20	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466566&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			155196358	441576272							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963937	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1	LGQIOUYNFUYGTH-YQQAZPJKSA-N	466567	US10800755, Example 21::US11014905, Example 21	5-hydroxytryptamine receptor 1A	Human		 15.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330153	441576273							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963938	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1	LGQIOUYNFUYGTH-YQQAZPJKSA-N	466567	US10800755, Example 21::US11014905, Example 21	D(4) dopamine receptor	Homo sapiens		 201							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330153	441576273							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963939	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1	LGQIOUYNFUYGTH-YQQAZPJKSA-N	466567	US10800755, Example 21::US11014905, Example 21	D(2) dopamine receptor	Homo sapiens		 2170							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330153	441576273							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963940	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H27N3O2/c1-14-3-2-4-17(20-14)15-5-9-21(10-6-15)11-8-19-18(22)16-7-12-23-13-16/h2-4,15-16H,5-13H2,1H3,(H,19,22)	ATMCUVOQKLCNNV-UHFFFAOYSA-N	466568	US10800755, Example 22::US11014905, Example 22	5-hydroxytryptamine receptor 1A	Human		 58.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466568&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330163	441576274							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963941	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H27N3O2/c1-14-3-2-4-17(20-14)15-5-9-21(10-6-15)11-8-19-18(22)16-7-12-23-13-16/h2-4,15-16H,5-13H2,1H3,(H,19,22)	ATMCUVOQKLCNNV-UHFFFAOYSA-N	466568	US10800755, Example 22::US11014905, Example 22	D(4) dopamine receptor	Homo sapiens		 2241							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466568&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330163	441576274							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963942	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H27N3O2/c1-14-3-2-4-17(20-14)15-5-9-21(10-6-15)11-8-19-18(22)16-7-12-23-13-16/h2-4,15-16H,5-13H2,1H3,(H,19,22)	ATMCUVOQKLCNNV-UHFFFAOYSA-N	466568	US10800755, Example 22::US11014905, Example 22	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466568	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466568&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330163	441576274							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963943	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25)	GGSIQDWKWRXJBY-UHFFFAOYSA-N	466569	US10800755, Example 23::US11014905, Example 25	5-hydroxytryptamine receptor 1A	Human		 166							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330154	441576275							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963944	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25)	GGSIQDWKWRXJBY-UHFFFAOYSA-N	466569	US10800755, Example 23::US11014905, Example 25	D(4) dopamine receptor	Homo sapiens		 408							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330154	441576275							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963945	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOC2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-3-1-2-15(23-16)13-4-8-24(9-5-13)10-7-22-17(25)14-6-11-26-12-14/h1-3,13-14H,4-12H2,(H,22,25)	GGSIQDWKWRXJBY-UHFFFAOYSA-N	466569	US10800755, Example 23::US11014905, Example 25	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466569	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466569&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330154	441576275							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963946	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H27N3O2/c1-14-4-2-5-16(20-14)15-7-10-21(11-8-15)12-9-19-18(22)17-6-3-13-23-17/h2,4-5,15,17H,3,6-13H2,1H3,(H,19,22)	NNKUZJKXZYNHAK-UHFFFAOYSA-N	466570	US10800755, Example 24::US11014905, Example 24	5-hydroxytryptamine receptor 1A	Human		 27.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466570&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330164	441576276							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963947	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H27N3O2/c1-14-4-2-5-16(20-14)15-7-10-21(11-8-15)12-9-19-18(22)17-6-3-13-23-17/h2,4-5,15,17H,3,6-13H2,1H3,(H,19,22)	NNKUZJKXZYNHAK-UHFFFAOYSA-N	466570	US10800755, Example 24::US11014905, Example 24	D(4) dopamine receptor	Homo sapiens		 3378							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466570&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330164	441576276							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963948	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H27N3O2/c1-14-4-2-5-16(20-14)15-7-10-21(11-8-15)12-9-19-18(22)17-6-3-13-23-17/h2,4-5,15,17H,3,6-13H2,1H3,(H,19,22)	NNKUZJKXZYNHAK-UHFFFAOYSA-N	466570	US10800755, Example 24::US11014905, Example 24	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466570	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466570&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330164	441576276							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963949	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-5-1-3-14(23-16)13-6-9-24(10-7-13)11-8-22-17(25)15-4-2-12-26-15/h1,3,5,13,15H,2,4,6-12H2,(H,22,25)	VEDJDJXYSXQHNT-UHFFFAOYSA-N	466571	US10800755, Example 25	5-hydroxytryptamine receptor 1A	Human		 20.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466571&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146360827	441576277							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963950	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-5-1-3-14(23-16)13-6-9-24(10-7-13)11-8-22-17(25)15-4-2-12-26-15/h1,3,5,13,15H,2,4,6-12H2,(H,22,25)	VEDJDJXYSXQHNT-UHFFFAOYSA-N	466571	US10800755, Example 25	D(4) dopamine receptor	Homo sapiens		 423							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466571&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146360827	441576277							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963951	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-5-1-3-14(23-16)13-6-9-24(10-7-13)11-8-22-17(25)15-4-2-12-26-15/h1,3,5,13,15H,2,4,6-12H2,(H,22,25)	VEDJDJXYSXQHNT-UHFFFAOYSA-N	466571	US10800755, Example 25	D(2) dopamine receptor	Homo sapiens		 3327							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466571&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146360827	441576277							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963952	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C21H33N3O2/c1-16-4-3-5-20(23-16)17-10-13-24(14-11-17)15-12-22-21(25)18-6-8-19(26-2)9-7-18/h3-5,17-19H,6-15H2,1-2H3,(H,22,25)/t18-,19-	OFDPWRMPOMJNHU-WGSAOQKQSA-N	466572	US10800755, Example 26::US11014905, Example 26	5-hydroxytryptamine receptor 1A	Human		 79.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466572&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330165	441576278							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963953	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C21H33N3O2/c1-16-4-3-5-20(23-16)17-10-13-24(14-11-17)15-12-22-21(25)18-6-8-19(26-2)9-7-18/h3-5,17-19H,6-15H2,1-2H3,(H,22,25)/t18-,19-	OFDPWRMPOMJNHU-WGSAOQKQSA-N	466572	US10800755, Example 26::US11014905, Example 26	D(4) dopamine receptor	Homo sapiens		 1902							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466572&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330165	441576278							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963954	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C21H33N3O2/c1-16-4-3-5-20(23-16)17-10-13-24(14-11-17)15-12-22-21(25)18-6-8-19(26-2)9-7-18/h3-5,17-19H,6-15H2,1-2H3,(H,22,25)/t18-,19-	OFDPWRMPOMJNHU-WGSAOQKQSA-N	466572	US10800755, Example 26::US11014905, Example 26	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466572	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466572&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330165	441576278							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963955	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C21H30F3N3O2/c1-29-17-7-5-16(6-8-17)20(28)25-11-14-27-12-9-15(10-13-27)18-3-2-4-19(26-18)21(22,23)24/h2-4,15-17H,5-14H2,1H3,(H,25,28)/t16-,17-	DFQSHXTUDLODFA-QAQDUYKDSA-N	466573	US10800755, Example 27::US11014905, Example 27	5-hydroxytryptamine receptor 1A	Human		 77.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466573&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330085	441576279							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963956	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C21H30F3N3O2/c1-29-17-7-5-16(6-8-17)20(28)25-11-14-27-12-9-15(10-13-27)18-3-2-4-19(26-18)21(22,23)24/h2-4,15-17H,5-14H2,1H3,(H,25,28)/t16-,17-	DFQSHXTUDLODFA-QAQDUYKDSA-N	466573	US10800755, Example 27::US11014905, Example 27	D(4) dopamine receptor	Homo sapiens		 2474							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466573&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330085	441576279							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963957	CO[C@H]1CC[C@@H](CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C21H30F3N3O2/c1-29-17-7-5-16(6-8-17)20(28)25-11-14-27-12-9-15(10-13-27)18-3-2-4-19(26-18)21(22,23)24/h2-4,15-17H,5-14H2,1H3,(H,25,28)/t16-,17-	DFQSHXTUDLODFA-QAQDUYKDSA-N	466573	US10800755, Example 27::US11014905, Example 27	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466573	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466573&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330085	441576279							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963958	FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	CRIIWZWMEASXGQ-UHFFFAOYSA-N	466574	US10800755, Example 28::US11014905, Example 28	5-hydroxytryptamine receptor 1A	Human		 28.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330152	441576280							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963959	FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	CRIIWZWMEASXGQ-UHFFFAOYSA-N	466574	US10800755, Example 28::US11014905, Example 28	D(4) dopamine receptor	Homo sapiens		 104							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330152	441576280							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963960	FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	CRIIWZWMEASXGQ-UHFFFAOYSA-N	466574	US10800755, Example 28::US11014905, Example 28	D(2) dopamine receptor	Homo sapiens		 2472							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330152	441576280							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963961	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23)	LWUCNZZPRVNCLB-UHFFFAOYSA-N	466575	N-[2-(6-Methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242;(2&#8242;H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29	5-hydroxytryptamine receptor 1A	Human		 0.400							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429259	441576281							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963962	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23)	LWUCNZZPRVNCLB-UHFFFAOYSA-N	466575	N-[2-(6-Methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242;(2&#8242;H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29	D(4) dopamine receptor	Homo sapiens		 22.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429259	441576281							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963963	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23)	LWUCNZZPRVNCLB-UHFFFAOYSA-N	466575	N-[2-(6-Methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242;(2&#8242;H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429259	441576281							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963964	Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22)	NSRFWSBDKAVEHH-UHFFFAOYSA-N	466576	2,2-Dimethyl-N-[2-(6-methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30	5-hydroxytryptamine receptor 1A	Human		 1.40							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429266	441576282							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963965	Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22)	NSRFWSBDKAVEHH-UHFFFAOYSA-N	466576	2,2-Dimethyl-N-[2-(6-methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30	D(4) dopamine receptor	Homo sapiens		 14.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429266	441576282							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963966	Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22)	NSRFWSBDKAVEHH-UHFFFAOYSA-N	466576	2,2-Dimethyl-N-[2-(6-methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429266	441576282							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963967	CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25)	MLIIQBGETYKWJT-UHFFFAOYSA-N	466577	2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31	5-hydroxytryptamine receptor 1A	Human		 0.300							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429285	441576283							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963968	CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25)	MLIIQBGETYKWJT-UHFFFAOYSA-N	466577	2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31	D(4) dopamine receptor	Homo sapiens		 2.90							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429285	441576283							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963969	CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25)	MLIIQBGETYKWJT-UHFFFAOYSA-N	466577	2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31	D(2) dopamine receptor	Homo sapiens		 1280							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429285	441576283							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963970	Fc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H26FN3O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H,20,23)	BUJBIVXDBXZHAP-UHFFFAOYSA-N	466578	US10800755, Example 32::US11014905, Example 32	5-hydroxytryptamine receptor 1A	Human		 42.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466578&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330087	441576284							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963971	Fc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H26FN3O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H,20,23)	BUJBIVXDBXZHAP-UHFFFAOYSA-N	466578	US10800755, Example 32::US11014905, Example 32	D(4) dopamine receptor	Homo sapiens		 96.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466578&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330087	441576284							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963972	Fc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H26FN3O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H,20,23)	BUJBIVXDBXZHAP-UHFFFAOYSA-N	466578	US10800755, Example 32::US11014905, Example 32	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466578	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466578&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330087	441576284							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963973	COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23)	NOINDEFTVTZLJT-UHFFFAOYSA-N	466579	US10800755, Example 33::US11014905, Example 33	5-hydroxytryptamine receptor 1A	Human		 21.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146330158	441576285							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963974	COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23)	NOINDEFTVTZLJT-UHFFFAOYSA-N	466579	US10800755, Example 33::US11014905, Example 33	D(4) dopamine receptor	Homo sapiens		 119							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330158	441576285							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963975	COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23)	NOINDEFTVTZLJT-UHFFFAOYSA-N	466579	US10800755, Example 33::US11014905, Example 33	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146330158	441576285							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963976	FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25)	BRSILCSYDNFMAA-UHFFFAOYSA-N	466580	US10800755, Example 34::US11014905, Example 34	5-hydroxytryptamine receptor 1A	Human		 10.00							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			146329998	441576286							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963977	FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25)	BRSILCSYDNFMAA-UHFFFAOYSA-N	466580	US10800755, Example 34::US11014905, Example 34	D(4) dopamine receptor	Homo sapiens		 56.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329998	441576286							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963978	FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25)	BRSILCSYDNFMAA-UHFFFAOYSA-N	466580	US10800755, Example 34::US11014905, Example 34	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			146329998	441576286							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963979	O=C(NCCN1CCC(CC1)c1cccc(n1)C#N)C1CCOCC1	InChI=1S/C19H26N4O2/c20-14-17-2-1-3-18(22-17)15-4-9-23(10-5-15)11-8-21-19(24)16-6-12-25-13-7-16/h1-3,15-16H,4-13H2,(H,21,24)	AYKNCXDOPYPPJV-UHFFFAOYSA-N	466581	N-{2-[4-(6-Cyanopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 35::US11014905, Example 35	5-hydroxytryptamine receptor 1A	Human		 278							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466581&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429258	441576287							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963980	O=C(NCCN1CCC(CC1)c1cccc(n1)C#N)C1CCOCC1	InChI=1S/C19H26N4O2/c20-14-17-2-1-3-18(22-17)15-4-9-23(10-5-15)11-8-21-19(24)16-6-12-25-13-7-16/h1-3,15-16H,4-13H2,(H,21,24)	AYKNCXDOPYPPJV-UHFFFAOYSA-N	466581	N-{2-[4-(6-Cyanopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 35::US11014905, Example 35	D(4) dopamine receptor	Homo sapiens		 2258							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466581&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429258	441576287							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963981	O=C(NCCN1CCC(CC1)c1cccc(n1)C#N)C1CCOCC1	InChI=1S/C19H26N4O2/c20-14-17-2-1-3-18(22-17)15-4-9-23(10-5-15)11-8-21-19(24)16-6-12-25-13-7-16/h1-3,15-16H,4-13H2,(H,21,24)	AYKNCXDOPYPPJV-UHFFFAOYSA-N	466581	N-{2-[4-(6-Cyanopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 35::US11014905, Example 35	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466581	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466581&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429258	441576287							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963982	Nc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H28N4O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H2,19,21)(H,20,23)	MMJQZWCPJZFPIH-UHFFFAOYSA-N	466582	N-{2-[4-(6-Aminopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 36::US11014905, Example 36	5-hydroxytryptamine receptor 1A	Human		 132							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466582&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429270	441576288							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963983	Nc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H28N4O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H2,19,21)(H,20,23)	MMJQZWCPJZFPIH-UHFFFAOYSA-N	466582	N-{2-[4-(6-Aminopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 36::US11014905, Example 36	D(4) dopamine receptor	Homo sapiens		 120							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466582&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429270	441576288							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963984	Nc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C18H28N4O2/c19-17-3-1-2-16(21-17)14-4-9-22(10-5-14)11-8-20-18(23)15-6-12-24-13-7-15/h1-3,14-15H,4-13H2,(H2,19,21)(H,20,23)	MMJQZWCPJZFPIH-UHFFFAOYSA-N	466582	N-{2-[4-(6-Aminopyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 36::US11014905, Example 36	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466582	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466582&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429270	441576288							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963985	CNc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H30N4O2/c1-20-18-4-2-3-17(22-18)15-5-10-23(11-6-15)12-9-21-19(24)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,22)(H,21,24)	MAOSODQBBXGYHQ-UHFFFAOYSA-N	466583	N-(2-{4-[6-(Methylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 37::US11014905, Example 37	5-hydroxytryptamine receptor 1A	Human		 108							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466583&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429271	441576289							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963986	CNc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H30N4O2/c1-20-18-4-2-3-17(22-18)15-5-10-23(11-6-15)12-9-21-19(24)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,22)(H,21,24)	MAOSODQBBXGYHQ-UHFFFAOYSA-N	466583	N-(2-{4-[6-(Methylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 37::US11014905, Example 37	D(4) dopamine receptor	Homo sapiens		 73.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466583&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429271	441576289							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963987	CNc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H30N4O2/c1-20-18-4-2-3-17(22-18)15-5-10-23(11-6-15)12-9-21-19(24)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,22)(H,21,24)	MAOSODQBBXGYHQ-UHFFFAOYSA-N	466583	N-(2-{4-[6-(Methylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 37::US11014905, Example 37	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466583	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466583&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429271	441576289							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963988	CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25)	CRPFIYXBQORQJX-UHFFFAOYSA-N	466584	N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38	5-hydroxytryptamine receptor 1A	Human		 37.0							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search			142429287	441576290							1	MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ		5-hydroxytryptamine receptor 1A	5HT1A_HUMAN	P08908	Q6LAE7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963989	CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25)	CRPFIYXBQORQJX-UHFFFAOYSA-N	466584	N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38	D(4) dopamine receptor	Homo sapiens		 10.00							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=4937&target=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=D%284%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429287	441576290							1	MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVATERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWTPFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC		D(4) dopamine receptor	DRD4_HUMAN	P21917	B0M0J7 Q7Z7Q5 Q8NGM5																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963990	CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25)	CRPFIYXBQORQJX-UHFFFAOYSA-N	466584	N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38	D(2) dopamine receptor	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804885	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search			142429287	441576290							1	MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC	7JVR,8IRS	D(2) dopamine receptor	DRD2_HUMAN	P14416	Q9NZR3 Q9UPA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
963991	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H26F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,14-15H,4-13H2,(H,26,29)	OEXMEESXYABYFA-UHFFFAOYSA-N	466535	4,4-Difluoro-N-(2-{4-[6-(trifluoromethyl)pyridin-2-yl]piperidin-1-yl}ethyl)cyclohexane-carboxamide::US10800755, Example 1::US11014905, Example 1	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 2500							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466535	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466535&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429260	441576241							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
963992	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-5,14-15H,2-3,6-13H2,(H,23,26)	IVMHGKYNLVHHQR-UHFFFAOYSA-N	466540	US10800755, Example 2	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466540	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466540&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155922394	441576246							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
963993	Cc1cccc(n1)C1CCN(CCNC(=O)C2CC3CCC2O3)CC1	InChI=1S/C20H29N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,15-17,19H,5-13H2,1H3,(H,21,24)	JQHNICFXWDNWAO-UHFFFAOYSA-N	466545	US10800755, Example 3::US11014905, Example 3	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 32100							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466545	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466545&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155922395	441576251							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
963994	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H29F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,16-17H,5-14H2,1H3,(H,23,26)	KQNGZWUJPKEOIL-UHFFFAOYSA-N	466547	US10800755, Example 4::US11014905, Example 4	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 4000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466547	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466547&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155922396	441576253							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
963995	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(C)n1	InChI=1S/C19H31N3O2/c1-15-6-5-7-17(21-15)16-8-11-22(12-9-16)13-10-20-18(23)19(2,3)14-24-4/h5-7,16H,8-14H2,1-4H3,(H,20,23)	HBHQINPAMGZPQL-UHFFFAOYSA-N	466549	US10800755, Example 5::US11014905, Example 5	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 48200							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466549	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466549&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155922397	441576255							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
963996	COCC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H28F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-6,14H,7-13H2,1-3H3,(H,23,26)	VLVHBCCFLHBDRZ-UHFFFAOYSA-N	466550	US10800755, Example 6::US11014905, Example 6	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 12800							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466550	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466550&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155922398	441576256							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
963997	COCC1(CC1)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-27-13-18(7-8-18)17(26)23-9-12-25-10-5-14(6-11-25)15-3-2-4-16(24-15)19(20,21)22/h2-4,14H,5-13H2,1H3,(H,23,26)	NEDKIEZVBKFWHQ-UHFFFAOYSA-N	466551	US10800755, Example 7	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 5600							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466551	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466551&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155922399	441576257							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
963998	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-4,16-17H,5-14H2,1H3,(H,20,23)	MMZCHCQVBLYIRF-UHFFFAOYSA-N	466552	N-{2-[4-(6-Methylpyridin-2-yl)piperidin-1-yl]ethyl}-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 8::US11014905, Example 8	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 44300							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466552	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466552&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429277	441576258							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
963999	CC(C)(C)C(=O)NCCN1CCC(CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H26F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-6,13H,7-12H2,1-3H3,(H,22,25)	WRRJZZBXRRDBBD-UHFFFAOYSA-N	466553	US10800755, Example 9::US11014905, Example 9	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 5900							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466553	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466553&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429268	441576259							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964000	Cc1cccc(n1)C1CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H29N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-7,15H,8-13H2,1-4H3,(H,19,22)	UDFOPUAGEBDRJQ-UHFFFAOYSA-N	466554	US10800755, Example 10::US11014905, Example 10	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466554	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466554&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155922400	441576260							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964001	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O2/c20-19(21,22)17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	OASSGMBDTDTXKO-UHFFFAOYSA-N	466555	US10800755, Example 11::US11014905, Example 11	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 12700							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466555	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466555&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429261	441576261							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964002	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H24F5N3O/c21-19(22)8-4-15(5-9-19)18(29)26-10-13-28-11-6-14(7-12-28)16-2-1-3-17(27-16)20(23,24)25/h1-3,6,15H,4-5,7-13H2,(H,26,29)	CFQKEDUZBWAPMC-UHFFFAOYSA-N	466556	4,4-Difluoro-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-cyclohexane-1-carboxamide::US10800755, Example 12::US11014905, Example 12	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 3500							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466556	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466556&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429255	441576262							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964003	Cc1cccc(n1)C1=CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H27N3O2/c1-14-3-2-4-18(22-14)15-7-10-23(11-8-15)12-9-21-20(24)17-13-16-5-6-19(17)25-16/h2-4,7,16-17,19H,5-6,8-13H2,1H3,(H,21,24)/t16-,17-,19+/m0/s1	WOHMWCGVHSYPFG-JENIJYKNSA-N	466557	US10800755, Example 13::US11014905, Example 13	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466557	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466557&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146330155	441576263							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964004	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCC(F)(F)CC2)CC1	InChI=1S/C20H27F2N3O/c1-15-3-2-4-18(24-15)16-7-12-25(13-8-16)14-11-23-19(26)17-5-9-20(21,22)10-6-17/h2-4,7,17H,5-6,8-14H2,1H3,(H,23,26)	SKSOBHHSERUEOI-UHFFFAOYSA-N	466559	US10800755, Example 14::US11014905, Example 14	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 8100							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466559	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466559&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146329996	441576265							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964005	Cc1cccc(n1)C1CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H29N3O2/c1-15-4-2-6-18(21-15)16-7-10-22(11-8-16)12-9-20-19(23)17-5-3-13-24-14-17/h2,4,6,16-17H,3,5,7-14H2,1H3,(H,20,23)	NKLHZQQLECBIFS-UHFFFAOYSA-N	466560	US10800755, Example 15::US11014905, Example 15	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466560	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466560&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146329997	441576266							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964006	FC(F)(F)c1cccc(n1)C1=CCN(CCNC(=O)C2CCCOC2)CC1	InChI=1S/C19H24F3N3O2/c20-19(21,22)17-5-1-4-16(24-17)14-6-9-25(10-7-14)11-8-23-18(26)15-3-2-12-27-13-15/h1,4-6,15H,2-3,7-13H2,(H,23,26)	LUQGVAHGIPCKGZ-UHFFFAOYSA-N	466561	N-{2-[6-(Trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}-tetrahydro-2H-pyran-3-carboxamide::US10800755, Example 16::US11014905, Example 16	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466561	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466561&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429276	441576267							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964007	COCC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C19H26F3N3O2/c1-18(2,13-27-3)17(26)23-9-12-25-10-7-14(8-11-25)15-5-4-6-16(24-15)19(20,21)22/h4-7H,8-13H2,1-3H3,(H,23,26)	QKTXOFXCKWUIEE-UHFFFAOYSA-N	466564	US10800755, Example 18::US11014905, Example 18	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466564	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466564&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146330226	441576270							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964008	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCCCO2)CC1	InChI=1S/C19H27N3O2/c1-15-5-4-6-17(21-15)16-8-11-22(12-9-16)13-10-20-19(23)18-7-2-3-14-24-18/h4-6,8,18H,2-3,7,9-14H2,1H3,(H,20,23)	MRPRDAAKTDVUPC-UHFFFAOYSA-N	466566	US10800755, Example 20	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466566	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466566&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			155196358	441576272							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964009	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)[C@H]2C[C@@H]3CC[C@H]2O3)CC1	InChI=1S/C20H26F3N3O2/c21-20(22,23)18-3-1-2-16(25-18)13-6-9-26(10-7-13)11-8-24-19(27)15-12-14-4-5-17(15)28-14/h1-3,13-15,17H,4-12H2,(H,24,27)/t14-,15-,17+/m0/s1	LGQIOUYNFUYGTH-YQQAZPJKSA-N	466567	US10800755, Example 21::US11014905, Example 21	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466567	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466567&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146330153	441576273							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964010	FC(F)(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCCO2)CC1	InChI=1S/C18H24F3N3O2/c19-18(20,21)16-5-1-3-14(23-16)13-6-9-24(10-7-13)11-8-22-17(25)15-4-2-12-26-15/h1,3,5,13,15H,2,4,6-12H2,(H,22,25)	VEDJDJXYSXQHNT-UHFFFAOYSA-N	466571	US10800755, Example 25	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466571	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466571&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146360827	441576277							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964011	FC(F)(F)Oc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H26F3N3O3/c20-19(21,22)28-17-3-1-2-16(24-17)14-4-9-25(10-5-14)11-8-23-18(26)15-6-12-27-13-7-15/h1-3,14-15H,4-13H2,(H,23,26)	CRIIWZWMEASXGQ-UHFFFAOYSA-N	466574	US10800755, Example 28::US11014905, Example 28	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466574	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466574&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146330152	441576280							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964012	Cc1cccc(n1)C1=CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27N3O2/c1-15-3-2-4-18(21-15)16-5-10-22(11-6-16)12-9-20-19(23)17-7-13-24-14-8-17/h2-5,17H,6-14H2,1H3,(H,20,23)	LWUCNZZPRVNCLB-UHFFFAOYSA-N	466575	N-[2-(6-Methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242;(2&#8242;H)-yl) ethyl]-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 29::US11014905, Example 29	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466575	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466575&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429259	441576281							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964013	Cc1cccc(n1)C1=CCN(CCNC(=O)C(C)(C)C)CC1	InChI=1S/C18H27N3O/c1-14-6-5-7-16(20-14)15-8-11-21(12-9-15)13-10-19-17(22)18(2,3)4/h5-8H,9-13H2,1-4H3,(H,19,22)	NSRFWSBDKAVEHH-UHFFFAOYSA-N	466576	2,2-Dimethyl-N-[2-(6-methyl-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl)ethyl]propanamide::US10800755, Example 30::US11014905, Example 30	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466576	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466576&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429266	441576282							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964014	CC(C)(C)C(=O)NCCN1CCC(=CC1)c1cccc(n1)C(F)(F)F	InChI=1S/C18H24F3N3O/c1-17(2,3)16(25)22-9-12-24-10-7-13(8-11-24)14-5-4-6-15(23-14)18(19,20)21/h4-7H,8-12H2,1-3H3,(H,22,25)	MLIIQBGETYKWJT-UHFFFAOYSA-N	466577	2,2-Dimethyl-N-{2-[6-(trifluoromethyl)-3&#8242;,6&#8242;-dihydro[2,4&#8242;-bipyridin]-1&#8242; (2&#8242;H)-yl]ethyl}propanamide::US10800755, Example 31::US11014905, Example 31	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466577	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466577&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429285	441576283							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964015	COc1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H29N3O3/c1-24-18-4-2-3-17(21-18)15-5-10-22(11-6-15)12-9-20-19(23)16-7-13-25-14-8-16/h2-4,15-16H,5-14H2,1H3,(H,20,23)	NOINDEFTVTZLJT-UHFFFAOYSA-N	466579	US10800755, Example 33::US11014905, Example 33	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466579	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466579&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146330158	441576285							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964016	FC(F)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C19H27F2N3O2/c20-18(21)17-3-1-2-16(23-17)14-4-9-24(10-5-14)11-8-22-19(25)15-6-12-26-13-7-15/h1-3,14-15,18H,4-13H2,(H,22,25)	BRSILCSYDNFMAA-UHFFFAOYSA-N	466580	US10800755, Example 34::US11014905, Example 34	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		 5500							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466580	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466580&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			146329998	441576286							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																														
964017	CN(C)c1cccc(n1)C1CCN(CCNC(=O)C2CCOCC2)CC1	InChI=1S/C20H32N4O2/c1-23(2)19-5-3-4-18(22-19)16-6-11-24(12-7-16)13-10-21-20(25)17-8-14-26-15-9-17/h3-5,16-17H,6-15H2,1-2H3,(H,21,25)	CRPFIYXBQORQJX-UHFFFAOYSA-N	466584	N-(2-{4-[6-(Dimethylamino)pyridin-2-yl]piperidin-1-yl}ethyl)-tetrahydro-2H-pyran-4-carboxamide::US10800755, Example 38::US11014905, Example 38	Potassium voltage-gated channel subfamily H member 2	Homo sapiens		>10000							US Patent		10.7270/Q2TM7F5J		aid1804886	US10800755	Yoshinaga, H; Uemachi, H; Ohno, T; Besnard, J	10/13/2020	6/1/2021	SUMITOMO DAINIPPON PHARMA CO., LTD.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=466584	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=466584&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search			142429287	441576290							1	MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS	1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1	Potassium voltage-gated channel subfamily H member 2	KCNH2_HUMAN	Q12809	A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0		Potassium voltage-gated channel subfamily H member 2	A0A090N8Q0_HUMAN	A0A090N8Q0